
               
               
               CLINICAL PHARMACOLOGY:
               
                  Corticoids suppress the inflammatory response to a variety of agents and they may delay healing. Since corticoids may inhibit the bodyâ€™s defense mechanism against infection, a concomitant antimicrobial drug may be used when this inhibition is considered to be clinically significant in a particular case.
                  The anti-infective components in the combination are included to provide action against specific organisms susceptible to them. Neomycin sulfate and polymyxin B sulfate together are considered active against the following microorganisms: species, species, and . This product does not provide adequate coverage against and streptococci, including .
                            Staphylococcus aureus, Escherichia coli, Haemophilus influenzae, Klebsiella-Enterobacter
                     Neisseria
                     Pseudomonas aeruginosa
                     Serratia marcescens
                     Streptococcus pneumoniae
                  
                  The relative potency of corticosteroids depends on the molecular structure, concentration, and release from the vehicle.
               
               
            
         